Cargando…
Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions
Interactions between different cell types are critical for a plethora of biological processes, such as the immune response. We recently developed a novel technology, called LIPSTIC (labeling of immune partnership by SorTagging intercellular contacts), that allows for identifying cells undergoing spe...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613713/ https://www.ncbi.nlm.nih.gov/pubmed/34870906 http://dx.doi.org/10.1002/cpz1.311 |
_version_ | 1783605514851057664 |
---|---|
author | Alberti, Dafne Guarniero, Michelle Maciola, Agnieszka K. Dotta, Enrico Pasqual, Giulia |
author_facet | Alberti, Dafne Guarniero, Michelle Maciola, Agnieszka K. Dotta, Enrico Pasqual, Giulia |
author_sort | Alberti, Dafne |
collection | PubMed |
description | Interactions between different cell types are critical for a plethora of biological processes, such as the immune response. We recently developed a novel technology, called LIPSTIC (labeling of immune partnership by SorTagging intercellular contacts), that allows for identifying cells undergoing specific interactions thanks to an enzymatic labeling reaction. Our work demonstrated the use of this technology to monitor interactions between immune cells, both in vitro and in vivo, by the genetic engineering of CD40 and CD40L, an essential costimulatory axis between antigen-presenting cells and T cells. Here we describe protocols to design novel LIPSTIC-engineered ligand and receptor pairs, clone constructs into retroviral expression vector, perform their initial validation, and use them to measure interactions ex vivo. This information will be useful to investigators interested in exploiting the LIPSTIC technology to track their favorite immune interaction. Basic Protocol 1: Design of LIPSTIC-engineered ligand and receptor pairs Basic Protocol 2: Cloning of LIPSTIC-engineered ligand and receptor pairs Basic Protocol 3: Validation of LIPSTIC-engineered ligand and receptor pairs in 293T cells Basic Protocol 4: Measuring interaction with LIPSTIC in immune cells ex vivo |
format | Online Article Text |
id | pubmed-7613713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-76137132022-10-15 Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions Alberti, Dafne Guarniero, Michelle Maciola, Agnieszka K. Dotta, Enrico Pasqual, Giulia Curr Protoc Article Interactions between different cell types are critical for a plethora of biological processes, such as the immune response. We recently developed a novel technology, called LIPSTIC (labeling of immune partnership by SorTagging intercellular contacts), that allows for identifying cells undergoing specific interactions thanks to an enzymatic labeling reaction. Our work demonstrated the use of this technology to monitor interactions between immune cells, both in vitro and in vivo, by the genetic engineering of CD40 and CD40L, an essential costimulatory axis between antigen-presenting cells and T cells. Here we describe protocols to design novel LIPSTIC-engineered ligand and receptor pairs, clone constructs into retroviral expression vector, perform their initial validation, and use them to measure interactions ex vivo. This information will be useful to investigators interested in exploiting the LIPSTIC technology to track their favorite immune interaction. Basic Protocol 1: Design of LIPSTIC-engineered ligand and receptor pairs Basic Protocol 2: Cloning of LIPSTIC-engineered ligand and receptor pairs Basic Protocol 3: Validation of LIPSTIC-engineered ligand and receptor pairs in 293T cells Basic Protocol 4: Measuring interaction with LIPSTIC in immune cells ex vivo 2021-12-01 /pmc/articles/PMC7613713/ /pubmed/34870906 http://dx.doi.org/10.1002/cpz1.311 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Alberti, Dafne Guarniero, Michelle Maciola, Agnieszka K. Dotta, Enrico Pasqual, Giulia Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions |
title | Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions |
title_full | Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions |
title_fullStr | Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions |
title_full_unstemmed | Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions |
title_short | Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions |
title_sort | engineering ligand and receptor pairs with lipstic to track cell-cell interactions |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613713/ https://www.ncbi.nlm.nih.gov/pubmed/34870906 http://dx.doi.org/10.1002/cpz1.311 |
work_keys_str_mv | AT albertidafne engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions AT guarnieromichelle engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions AT maciolaagnieszkak engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions AT dottaenrico engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions AT pasqualgiulia engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions |